Tenaya Therapeutics, Inc. (TNYA) insider trading.
In Q3 2026, insiders at Tenaya Therapeutics, Inc. reported 10 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $21K.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 8
- Net shares, P minus S
- -29,656
- Insiders
- 2
- Last filed
- 2026-09-11
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Tingley Whittemore | Officer · Chief Medical Officer | 5 | 0 | 4 |
| Ali Faraz | Director, Officer · Chief Executive Officer | 5 | 0 | 4 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tingley Whittemore | A (A) | 49,000 | $0 | 263,073 | Form 4 |
| 2026-09-10 | Ali Faraz | A (A) | 122,000 | $0 | 539,782 | Form 4 |
| 2026-08-17 | Tingley Whittemore | S (D) | 1,637 | $0.71 | 219,860 | Form 4 |
| 2026-08-17 | Tingley Whittemore | S (D) | 1,871 | $0.71 | 216,352 | Form 4 |
| 2026-08-17 | Tingley Whittemore | S (D) | 2,279 | $0.71 | 214,073 | Form 4 |
| 2026-08-17 | Tingley Whittemore | S (D) | 1,637 | $0.71 | 218,223 | Form 4 |
| 2026-08-17 | Ali Faraz | S (D) | 5,020 | $0.71 | 425,188 | Form 4 |
| 2026-08-17 | Ali Faraz | S (D) | 7,406 | $0.71 | 417,782 | Form 4 |
| 2026-08-17 | Ali Faraz | S (D) | 5,837 | $0.71 | 434,177 | Form 4 |
| 2026-08-17 | Ali Faraz | S (D) | 3,969 | $0.71 | 430,208 | Form 4 |
Transaction codes in this quarter
Get TNYA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1858848&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TNYA company page · Tenaya Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Tenaya Therapeutics, Inc. (TNYA)?
In Q3 2026, insiders at Tenaya Therapeutics, Inc. reported 10 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 8 sales worth $21K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Tenaya Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tnya.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.